Europe — EMA
Olmita (Olmesartan Medoxomil, Amlodipine)
Olmesartan medoxomil, the active ingredient in Olmita, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxomil, the active ingredient in Olmita, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults. It works in conjunction with amlodipine, a calcium‑channel blocker, to provide complementary blood pressure control.
GNH USA supplies Olmita as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmita combines the antihypertensive effects of both the angiotensin II pathway and the calcium channel pathway in the treatment of high blood pressure. - Hypertension: Improves blood pressure control by dual block of the renin‑ren‑R R R R R R .... - Chronic Heart Failure … … ... … ... .... .... .... .... ... ... ... ... . - .... ... .... .... ...
What are the side effects of Olmesartan Medoxomil, Amlodipine?
....
What precautions apply to Olmesartan Medoxomil, Amlodipine?
....
What does Olmesartan Medoxomil, Amlodipine interact with?
....
